Furthermore, loss of function mutations in STAG2 occurs in 17% of Ewing sarcoma and is associated with a more aggressive tumour phenotype both in clinical studies and in murine xenograft models [59, 76]. Here, STAG2 is linked to Ewing sarcoma.